Law Firm Launches Securities Probe Into Tennant After Earnings Miss

BenzingaBenzinga
|||1 min read
Key Takeaway

Law firm investigates Tennant Company for potential securities violations after massive earnings miss attributed to ERP system implementation problems. Stock fell 23.4%.

Law Firm Launches Securities Probe Into Tennant After Earnings Miss

The Law Offices of Howard G. Smith has initiated an investigation into Tennant Company (NYSE: TNC) regarding potential violations of federal securities laws, following the cleaning equipment manufacturer's significant earnings disappointment on February 23, 2026. The company reported earnings per share of $0.48 against analyst expectations of $1.70, while revenue reached $291.6 million compared to consensus forecasts of $320.45 million—representing substantial shortfalls on both metrics.

Tennant attributed the weaker-than-expected financial performance to operational disruptions stemming from the implementation of a new enterprise resource planning (ERP) system. The company cited complications in order management and manufacturing scheduling that resulted in delayed customer deliveries. The earnings miss triggered an immediate market reaction, with Tennant's stock price declining 23.4% to close at $63.02 per share following the announcement.

The investigation examines whether Tennant's disclosures regarding the ERP implementation risks and potential operational impacts were adequate and timely, or if shareholders were insufficiently informed of material risks that materialized in the reported quarter. Investors who experienced losses in Tennant shares are being encouraged to contact the law firm to discuss potential recovery options.

Source: Benzinga

Back to newsPublished Feb 25

Related Coverage

Benzinga

Camping World Hit With Securities Fraud Suit Over Inventory Claims

DJS Law Group files class action against $CWH for allegedly making false statements about inventory management capabilities, harming profitability.

CWH
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
Investing.com

D-Wave's 44% Plunge Masks Quantum Leap: Growth Story vs. Valuation Reality

D-Wave ($QBTS) fell 44% in 2026 despite strong bookings exceeding 2025 totals and $30M in major deals. Analysts see 132% upside, but 237x sales valuation remains extreme.

QBTS
GlobeNewswire Inc.

OneMain Holdings Faces Multi-State Securities Probe Over Alleged Lending Fraud

Pomerantz Law Firm investigates $OMF following multi-state lawsuit alleging deceptive lending practices. Stock tumbles 5.38% on fraud allegations.

OMF
GlobeNewswire Inc.

MVST Stock Plunges 34% After Disastrous Earnings; Law Firm Launches Fraud Investigation

Microvast ($MVST) plunged 34% after reporting $96.5M revenue (29% below consensus) and 1% gross margins, triggering securities fraud investigation by Pomerantz LLP.

MVSTMVSTW
Benzinga

KB Home Shares Slide on 23% Revenue Decline, Margin Compression in Q1

KB Home stock fell 4.8% after Q1 earnings missed expectations, with revenue down 23% year-over-year and operating margins compressed to 3.1%.

KBH